Pulmonx appoints Alissa Hsu Lynch and Tiffany Sullivan as Class I directors

Pulmonx Corp

Appointments effective July 29, 2021; directors serve until 2024 annual meeting.
Lynch joins Audit Committee; Sullivan joins Nominating and Corporate Governance Committee.
Each receives $40k annual cash fee, initial RSU grant of $180k vesting over 3 years, plus annual equity grants.
Each enters standard indemnification agreement with Pulmonx.

item 5.02

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Appointed

Alissa Hsu Lynch

Class I Director

LUNG · Pulmonx Corp

Effective: 2021-07-29
Filed: August 2, 2021, 7:59 PM ET

Effective as of July 29, 2021, the Company’s Board of Directors (the “Board”) appointed Ms. Alissa Hsu Lynch and Ms. Tiffany Sullivan and to serve as Class I directors of the Board.

Appointed

Tiffany Sullivan

Class I Director

LUNG · Pulmonx Corp

Effective: 2021-07-29
Filed: August 2, 2021, 7:59 PM ET

Effective as of July 29, 2021, the Company’s Board of Directors (the “Board”) appointed Ms. Alissa Hsu Lynch and Ms. Tiffany Sullivan and to serve as Class I directors of the Board.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Alissa Hsu Lynch was appointed as Class I Director at Pulmonx Corp.

Action: appointed
Role: Class I Director

Exact text from the filing

Effective as of July 29, 2021, the Company’s Board of Directors (the “Board”) appointed Ms. Alissa Hsu Lynch and Ms. Tiffany Sullivan and to serve as Class I directors of the Board.

View on SEC.gov

Executive change SEC 8-K Item 5.02 confidence 0.95

Tiffany Sullivan was appointed as Class I Director at Pulmonx Corp.

Action: appointed
Role: Class I Director

Exact text from the filing

Effective as of July 29, 2021, the Company’s Board of Directors (the “Board”) appointed Ms. Alissa Hsu Lynch and Ms. Tiffany Sullivan and to serve as Class I directors of the Board.

View on SEC.gov

Pulmonx Corp filing history →

Source: SEC EDGAR

accession 0001127537-21-000033

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.